4.7 Article

Bone critical defect repair with poloxamine-cyclodextrin supramolecular gels

Journal

INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume 495, Issue 1, Pages 463-473

Publisher

ELSEVIER
DOI: 10.1016/j.ijpharm.2015.09.003

Keywords

Simvastatin; BMP-2; Poloxamine; alpha-Cyclodextrin; Gels; Bone regeneration; Syringeability; Critical bone defect

Funding

  1. Beca CajaCanarias para posgraduados
  2. FCT (Fundacao para a Ciencia e a Tecnologia) [SFRH/BPD/105327/2014]

Ask authors/readers for more resources

The aim of this study was to evaluate the osteoinductive capacity of a poloxamine (Tetronic (R) 908, T) and alpha-cyclodextrin (alpha CD) supramolecular gel (T-CD) as scaffold in a critical size defect in rat calvaria. The T-CD gel was evaluated solely and after being loaded with simvastatin (SV) and bone morphogenetic protein (BMP-2) separately and in combinations in order to reduce the doses of the active substances. Three doses of SV (7.5, 75, 750 mu g) and two doses of BMP-2 (3 and 6 mu g) were tested. The histology and histomorphometrical analysis showed improved bone repair with T-CD compared to T, probably due to better release control of both SV and BMP-2. In addition, as T-CD eroded more slowly than poloxamine alone, it remained longer in the defect site. Although synergism was not obtained with BMP-2 and SV, according to the observed regeneration of the defect, the dose of BMP-2 and SV can be reduced to 3 mu g and 7.5 mu g, respectively. (C) 2015 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available